Alnylam Pharmaceuticals, Inc. (0HD2.L)

USD 255.29

(-2.5%)

Inventory Summary of Alnylam Pharmaceuticals, Inc.

  • Alnylam Pharmaceuticals, Inc.'s latest annual inventory in 2023 was 89.14 Million USD , down -30.87% from previous year.
  • Alnylam Pharmaceuticals, Inc.'s latest quarterly inventory in 2024 Q2 was 83.98 Million USD , down -10.65% from previous quarter.
  • Alnylam Pharmaceuticals, Inc. reported annual inventory of 128.96 Million USD in 2022, up 49.33% from previous year.
  • Alnylam Pharmaceuticals, Inc. reported annual inventory of 86.36 Million USD in 2021, up 14.84% from previous year.
  • Alnylam Pharmaceuticals, Inc. reported quarterly inventory of 75.98 Million USD for 2024 Q3, down -9.52% from previous quarter.
  • Alnylam Pharmaceuticals, Inc. reported quarterly inventory of 83.98 Million USD for 2024 Q2, down -10.65% from previous quarter.

Annual Inventory Chart of Alnylam Pharmaceuticals, Inc. (2023 - 2012)

Historical Annual Inventory of Alnylam Pharmaceuticals, Inc. (2023 - 2012)

Year Inventory Inventory Growth
2023 89.14 Million USD -30.87%
2022 128.96 Million USD 49.33%
2021 86.36 Million USD 14.84%
2020 75.2 Million USD 33.46%
2019 56.34 Million USD 134.12%
2018 24.06 Million USD 2406799900.0%
2017 1.00 USD 0.0%
2016 1.00 USD 0.0%
2015 1.00 USD 0.0%
2014 - USD -100.0%
2013 1.00 USD 0.0%
2012 - USD 0.0%

Peer Inventory Comparison of Alnylam Pharmaceuticals, Inc.

Name Inventory Inventory Difference
uniQure N.V. 12.02 Million USD -641.401%
Agios Pharmaceuticals, Inc. 19.07 Million USD -367.32%
Amicus Therapeutics, Inc. 59.69 Million USD -49.333%
Atara Biotherapeutics, Inc. 9.7 Million USD -818.463%
bluebird bio, Inc. 22.91 Million USD -288.961%
Cara Therapeutics, Inc. 2.82 Million USD -3060.085%
Imunon, Inc. - USD -Infinity%
Editas Medicine, Inc. - USD -Infinity%
IQVIA Holdings Inc. - USD -Infinity%
Mettler-Toledo International Inc. 385.86 Million USD 76.897%
Myriad Genetics, Inc. 20.1 Million USD -343.512%
Neurocrine Biosciences, Inc. 38.3 Million USD -132.757%
Supernus Pharmaceuticals, Inc. 77.4 Million USD -15.164%
Verastem, Inc. - USD -Infinity%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 98.929%
Waters Corporation 516.23 Million USD 82.732%
Thermo Fisher Scientific Inc. 5.08 Billion USD 98.248%
Biogen Inc. 2.52 Billion USD 96.473%
Nektar Therapeutics 16.1 Million USD -453.667%
Perrigo Company plc 1.14 Billion USD 92.186%
Dynavax Technologies Corporation 53.29 Million USD -67.285%
Illumina, Inc. 587 Million USD 84.813%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 10.37 Million USD -759.487%
Heron Therapeutics, Inc. 42.11 Million USD -111.698%
Unity Biotechnology, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 91.948%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -710.566%
Adicet Bio, Inc. - USD -Infinity%
Aclaris Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 96.545%
Esperion Therapeutics, Inc. 65.62 Million USD -35.846%
FibroGen, Inc. 41.56 Million USD -114.474%
Agilent Technologies, Inc. 1.03 Billion USD 91.353%
OPKO Health, Inc. 65.69 Million USD -35.693%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Exelixis, Inc. 17.32 Million USD -414.611%
Viking Therapeutics, Inc. - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 96.523%
Axsome Therapeutics, Inc. 15.13 Million USD -489.006%
Abeona Therapeutics Inc. -2.44 Million USD 3747.545%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 87.934%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD -213.618%
Sarepta Therapeutics, Inc. 322.85 Million USD 72.389%
Corcept Therapeutics Incorporated 7.73 Million USD -1053.247%
Halozyme Therapeutics, Inc. 127.6 Million USD 30.137%
Blueprint Medicines Corporation 21.22 Million USD -320.044%
Insmed Incorporated 83.24 Million USD -7.085%
TG Therapeutics, Inc. 39.82 Million USD -123.856%
Incyte Corporation 62.97 Million USD -41.565%
Emergent BioSolutions Inc. 328.9 Million USD 72.896%